Navigation Links
Duke receives new grant for AIDS vaccine research
Date:7/18/2012

DURHAM, N.C. -- The Bill & Melinda Gates Foundation has awarded a new grant to Duke University Medical Center for work developing vaccines that can induce IgA antibodies for preventing HIV-1 infection. This award comes from the Gates' Collaboration for AIDS Vaccine Discovery (CAVD) program.

Late in 2011, Duke also won three grants from CAVD that totaled $37.2 million.

The latest grant award is a 3-year, $8.9 million grant to Barton Haynes, M.D., a national leader in AIDS/HIV research and director of the Center for HIV/AIDS Vaccine Immunology (CHAVI), as well as director of the Duke Human Vaccine Institute (DHVI).

The award stems from promising discoveries from the analysis of the how a partially effective HIV-1 vaccine might have worked, that was carried out under Dr. Haynes' leadership. Haynes led a multinational group that analyzed a wealth of data from the RV144 trial in Thailand, which tested a combination vaccine for efficacy.

"We are grateful to the Gates Foundation and its Collaboration for AIDS Vaccine Discovery for their continued support that lets us explore important new findings," said Haynes, who is Frederic M. Hanes Professor of Medicine and Immunology at Duke. "We believe the latest analyses are yielding critical information, and we are poised to move into promising new phases of studies for vaccine development in the fight against AIDS."

This CAVD award will fund research into ways to induce protective IgA human antibodies by vaccines to prevent HIV-1 infection, as well as to learn how to not induce IgA antibodies that might block the protective effect of other antibodies. In learning how to induce the right IgAs, recombinant IgAs will be produced to be tested as therapies to prevent HIV.

The new award will support work to elaborate on studies recently completed by Haynes and his Duke colleague Georgia Tomaras, Ph.D., who found that IgA was induced in plasma in the RV144 HIV prevention trial. Tomaras showed that one type of IgA induced by the RV144 vaccine could possibly reduce the effects of other types of potentially protective antibodies that might limit the rate of infection.

With the CAVD grant, the researchers hope to develop strategies to induce forms of IgA with anti-HIV-1 activity at the sites of transmission of HIV, and to perform studies in non-human primates using differing types of IgAs and IgA-inducing immunogens to determine protection levels against HIV infection.

Dr. Haynes' other recent CAVD grant, awarded late in 2011, is funding studies of the best way to create effective immunogens that mimic the proteins on the HIV outer envelope for induction of another type of antibody, called IgG. The immunogens will work to stimulate the right IgG antibodies to prevent virus transmission. The grant will provide $11.7 million over three years.

Haynes will work closely with a team led by David Montefiori, Ph.D., professor of surgery and director of the Laboratory for AIDS Vaccine Research and Development in the Duke Department of Surgery. The Gates Foundation in December 2011 awarded a 5-year, $24.6 million CAVD grant to Montefiori and his collaborators to develop laboratory tests for the study of future vaccine trials as well as to work with other CAVD teams and learn how to induce protective antibodies.


'/>"/>

Contact: Mary Jane Gore
mary.gore@duke.edu
919-660-1309
Duke University Medical Center
Source:Eurekalert

Related medicine news :

1. MCG student receives national medical honor society research fellowship
2. Gladstones Lennart Mucke receives Lifetime Achievement Award from the Alzheimers Association
3. JHU Bioethics Institute receives PCORI pilot project award
4. SUNY Downstate receives award to develop mobile phone apps for stroke patients and their caregivers
5. Einstein receives nearly $5 million to study how Ebola causes infection
6. Eye doctor receives Visionary Award
7. Cuff Repair Plate™ Receives Design and Utility Patents
8. Special Needs Spotlight: Former SFMTA Board Member Bruce Oka Receives Treatment with San Francisco Sedation Dentist Dr. David Blende
9. Clifford Saper, MD, PhD, receives Distinguished Scientist Award from the Sleep Research Society
10. Johns Hopkins African bioethics program receives 5-year continuation grant from NIH
11. Aging Brain Care model receives $7.8 million in CMS innovation funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2017)... ... August 19, 2017 , ... Praeclarus Press ... mothers. These illustrations show the diversity of the breastfeeding mothers, using bright ... range of sizes. These illustrations are also available on tote bags, notepads, smartphone ...
(Date:8/18/2017)... ... August 19, 2017 , ... Mr. Noppadon Pakprot, Deputy ... Amazing Thailand Health and Wellness Tourism Showcase 2017 yesterday, which unveiled the latest ... for Tourism Products and Business at TAT said, “Thailand has long been recognized ...
(Date:8/18/2017)... ... August 18, 2017 , ... August ... “Vision & Hearing,” advocating for active, healthy lifestyles and highlighting the importance of ... individuals with hearing impairments and shares the latest innovations in hearing aid technology. ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... consulting services and asset protection assistance to communities in North-Central West Virginia, is ... critical services to at-risk boys in the area. , The Chestnut Mountain Ranch ...
(Date:8/18/2017)... ... 2017 , ... The Golseth Agency, a Texas based insurance management and financial ... regional charity campaign organized to provide support to Christina Upchurch and her two children ... and her children returned from out of town to find her husband passed away ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Aug. 15, 2017   Mostyn Law and Gulf Coast ... Houston, Texas . The Mostyn Law family has ... years. That is why Mostyn Law is partnering with ... to show its appreciation. Blood supplies are running low. ... short of hospital needs in August. That is why the blood ...
(Date:8/15/2017)... N.C. , Aug. 15, 2017  Axium Pharmaceuticals Inc., the creator ... rumored to be in the beginning stages of an IPO. ... on epilepsy medications with the average cost of a prescription epilepsy drug ... ... Another staggering figure is the fact ...
(Date:8/15/2017)... , Aug. 15, 2017  AOTI Inc. announced today that its ... Inc., has recently opened a New York City Office in ... of its unique Topical Wound Oxygen (TWO 2 ) homecare therapy. ... Accreditation Commission for Health Care (ACHC) under the company,s DMEPOS accreditation ... ...
Breaking Medicine Technology: